Supernus Pharmaceuticals, Inc.
NASDAQSUPN short interest plummets 31% in one week to 8.7% of float, driven by sharp cover-down from elevated 7.3M-share position mid-July.
Snapshot as of 5 Aug 2026
No long-form analysis yet for SUPN. Pulse alerts and the live data picture are available on ORTEX.
Open SUPN on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SUPN — free to start on ORTEX.
Sign up for free →Open SUPN on ORTEX